ABSTRACT
INTRODUCTION
In a meta-analysis 1 with 20 studies, the prevalence of posttraumatic stress disorder (PTSD) in psychosis was estimated to be 12.4% (95% CI, 4.0%-20.8%).The presence of comorbid PTSD is associated with poorer social functioning and more severe psychiatric symptoms. [2] [3] [4] There is strong empirical support for the efficacy of prolonged exposure (PE) therapy and eye movement desensitization and reprocessing (EMDR) therapy in treating PTSD. 5, 6 These treatments are recommended as first-choice therapy in PTSD guidelines worldwide. 7, 8 However, clinicians seem reluctant to treat PTSD in individuals with psychosis. 9, 10 Patients with psychotic disorders have been excluded from randomized clinical trials [11] [12] [13] and psychosis is the most frequently applied exclusion criterion. 14 Nevertheless, evidence suggests that trauma-focused treatments can be effective in this patient population. A randomized clinical trial tested an evidence based intervention for PTSD (cognitive restructuring) 15 in patients with severe mental illness and found modest results. 16 However, only 16% of the participants had schizophrenia or schizoaffective disorder. Two small open pilot studies (in PE 17 and EMDR 18 ) and a controlled case series study 19 (PE and EMDR) found large effects on PTSD and no adverse events. Overall, robust evidence for the efficacy and safety of PE and EMDR in patients with psychosis is lacking.
This study aimed to examine the efficacy and safety of PE and EMDR in reducing PTSD, compared with a waiting list (WL) condition in individuals with psychotic disorders receiving treatment as usual for psychosis. To enhance clinical relevance, the trial was designed with features that mimic clinical practice. 20 A representative sample was acquired by applying a minimum of exclusion criteria. The study was conducted in 13 outpatient mental health services and used basic treatment protocols, delivered by therapists with different levels of expertise in the target treatments. During the trial non-trauma-focused cotherapies were allowed. We hypothesized that PE and EMDR compared with WL would both be effective and safe. In comparing PE and EMDR headto-head, we expected no statistical differences due to insufficient statistical power to detect small effect sizes.
METHODS

Design
The trial design was approved by the medical ethics committee of the VU University Medical Center and was registered at isrctn.com (ISRCTN79584912). Participants gave written informed consent before enrollment. Full details of the study methods and selection of participants are published elsewhere. 21 This study is a single-blind randomized clinical trial with 3 arms, including PE therapy, EMDR therapy, and WL.
With a medium effect size between conditions, a power of 0.80 and an α level of .05, we needed 159 participants.
Participants
The participants were recruited in 13 Dutch comparable outpatient services for patients with severe mental illnesses. Inclusion criteria were: (1) age 18 to 65 years; (2) a lifetime diagnosis of a psychotic disorder or mood disorder with psychotic features according to the Mini-International Neuropsychiatric Interview-Plus; 22, 23 and (3) satisfaction of the full DSM-IV-TR 24 diagnostic criteria for chronic PTSD on the Clinician-Administered PTSD Scale (CAPS). 25, 26 The PTSD severity was rated over the last week, and symptoms were considered present when they occurred at least once a week (frequency ≥ 2).
Exclusion criteria were (1) an extremely high acute suicide risk, operationalized as meeting all three of the following criteria (current high suicidality score on the MiniInternational Neuropsychiatric Interview-Plus, a serious suicide attempt within the past 6 months, and a depression score of ≥ 35 on the Beck Depression Inventory-II 27, 28 ); (2) changes in antipsychotic or antidepressant medication regimen within two months before the assessment (to control for medication effects on PTSD symptoms); (3) insufficient competence in the Dutch language; (4) severe intellectual impairment, defined as an estimated IQ of 70 or less (mental retardation); (5) not being able to travel (or be accompanied) to the outpatient service; and (6) current involuntary admission in a closed ward. The presence of current psychotic symptoms was not an exclusion criterion.
Measures
Assessors were blinded to treatment allocation. The 2-way mixed single measures (consistency) intraclass correlation coefficient for CAPS severity among all assessors over 20 randomly selected cases was 0.81.
Assessors and therapists emphasized the importance of blinding to the participants and repeatedly reminded them not to reveal the randomized treatment condition. Assessors avoided contact with the therapists and other caregivers. With these procedures, 27
incidents of unblinding occurred (11 in PE, 11 in EMDR, and 5 in WL). In case of unblinding another assessor repeated the entire measurement.
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The primary outcome measure was the CAPS 25 which provides a symptom severity score, and assesses the presence of a PTSD diagnosis. Full remission (CAPS total score <20) 26 was also evaluated. The CAPS was administered once over a maximum of 3 index traumas that were most strongly related to PTSD symptom severity. Traumatic psychotic experiences (eg, being physically secluded or restrained in a psychiatric hospital) were accepted as criterion-A traumas when these events met DSM-IV-TR A1 and A2 criteria.
Secondary outcome measures were the Posttraumatic Stress Symptom Scale SelfReport (PSS-SR), 29 which assesses self-reported frequency of PTSD symptoms, and the Posttraumatic Cognitions Inventory (PTCI) 30 which measures trauma-related cognitive distortions. All outcome measures were assessed at baseline, posttreatment and at 6-months follow-up. Demographic characteristics were recorded at baseline. Patients could also be referred for an inclusion interview (stage 2). An independent randomization bureau randomized the treatment condition using stratified randomization blocks per therapist with equal strata sizes. Therapists confirmed the treatment assignment in writing. Data were stored at the study coordination center.
Early completion was allowed when the PSS-SR scores were 10 or less on 2 consecutive occasions and the Subjective Units of Distress Scale score of all memories in the treatment plan was zero. To this end, the PSS-SR was administered before every session in the PE and EMDR conditions. After the 6-month follow-up assessment, participants in the WL condition were offered their treatment of choice. All participants received a financial compensation of €25 (US $31) for each assessment.
Treatment
All participants in the trial received comparable treatment as usual for psychosis delivered by multidisciplinary assertive outreach teams, with care usually consisting of antipsychotic medication and treatment and/or supportive counseling by psychologists, caseworkers, nurses, or psychiatrists. In the WL condition participants were seen once by the study therapist and informed about the PTSD diagnosis and further course of the study. Also, an appointment was made for the start of their treatment of choice after the 6-month follow-up period.
Both the PE and EMDR therapy were delivered in 8 weekly 90-minute sessions within a 10-week time frame. We did not aim to provide full therapy but rather to test an effective dosage of therapy that falls within the ranges in which PE and EMDR therapy have been found to be effective, 32, 33 also in this population. 18 In both conditions, the therapist and participant developed a standardized case conceptualization in the first session, which consisted of a hierarchy of relevant traumatic experiences. The PE therapy was conducted based on the protocol by Foa et al. 34 and imaginal exposure was used in sessions 2 through 8. Each session was audio recorded. Participants listened to these recordings 5 times per week. In sessions 3 through 8, in vivo exposure (based on a list of avoided trauma-related stimuli) was added. The EMDR was conducted according to the standard 8-phase protocol by Shapiro 35 using the Dutch translation of the EMDR protocol. 36 Eye movements were applied as the dual attention stimulus. In sessions 2 through 8, memories were processed. 35 The therapists were 19 clinical psychologists and 1 psychiatrist. Of these, 2 were already trained (a minimum of 4 days) in PE and 4 in EMDR. All other therapists received 4-day training in both PE and EMDR and treated at least 2 supervised cases per treatment during training. All therapists delivered both treatments. Non-trauma-focused therapies were allowed. However, participants and caregivers were instructed not to start any other form of trauma-focused treatment (eg, PE, EMDR, cognitive therapy, or imagery rescripting), to keep medications unchanged, and to report any adverse events or deviations from standard care. After treatment and at the 6-month follow-up, patient files were reviewed to check whether trauma-focused treatments had taken place and if there had been any changes in the prescribed medications, as well as for any deviations from standard care.
Supervision and Fidelity monitoring
Four hours of group supervision (group size, 6-8) were provided each month by experts in the target treatments (2 hours by A.Van M. in PE and 2 hours by C.de R. or A.de J. in EMDR). Additional supervision by telephone or e-mail was provided on request.
All treatment sessions were videotaped; of these sessions, 10%were randomly selected and rated by trained raters who were blinded to treatment outcome. Raters determined therapist competence and adherence to the treatment protocols. were computed according to Cohen d 38 using estimated data from the LMM procedure.
Baseline differences in demographic and clinical characteristics were analyzed using χ² test, t tests and analysis of variance. The number needed to treat was calculated to determine the number of participants who needed to be treated to make one more patient lose diagnosis or achieve full remission compared with the control condition. 39 
RESULTS
FIGURE 1
shows the participant flow through the study. In total, 440 inclusion interviews were conducted, and 155 participants were randomized. There were significant effects on the mean CAPS total scores for both treatments compared with WL at posttreatment and 6-month follow-up. There were no significant differences between PE and EMDR.
Outcomes on loss of PTSD diagnosis and full remission of PTSD are listed in According to the logistic generalized estimating equation analyses, participants in both the PE and EMDR conditions were more likely to achieve and maintain loss of PTSD diagnosis than participants in the WL condition. Participants in the PE condition, but not those in the EMDR condition, were more likely to achieve full remission of PTSD than participants in the WL condition. The PE and EMDR did not significantly differ in loss of PTSD diagnosis and full remission.
Self-reported PTSD symptoms (on the PSS-SR) and posttraumatic cognitions (on the PTCI) yielded results that were similar to the CAPS findings (FIGURE 2 and TABLE 2).
The PSS-SR and PTCI scores were lower for both treatment conditions compared with · 50 · the WL condition at posttreatment and 6-month follow-up. There were no significant differences between the PE and EMDR.
There was no difference in dropout between the PE (13 participants [24.5%]) and EMDR (11 participants [20.0%]) (P = .57). There were 8 early completers in PE (15.1%) and 2 in EMDR (3.6%); this difference was not statistically significant (P = .09). The mean number of treatment sessions attended by treatment completers was 7.1 in PE and 7.8 in EMDR (P = .007). All severe adverse events were reported to the medical ethics committee.
There were 2 severe adverse events in PE, 1 in EMDR, and 4 in WL. However, none of the severe adverse events were judged to have been induced by the study.
There were no differences between groups in additional support provided by caregivers.
Groups did not differ in the percentage of participants receiving additional non-trauma 
Sensitivity analyses
Completer analyses were performed (n = 113), among which no baseline differences were observed between groups in any of the demographic or clinical characteristics. In addition, intent-to-treat analyses with last observation carried forward were performed (n = 155). All results for the CAPS, PSS-SR, and PTCI were similar to the results from the intent-to-treat analyses, thereby underlining the robustness of the findings (TABLE 3) . 
PSS-SR Total Score
The intent-to-treat sample comprised 155 participants at baseline, 130 participants at posttreatment, and 128 participants at the 6-month follow-up.
CAPS indicates Clinician-Administered PTSD Scale; EMDR, eye movement desensitization and reprocessing; PE, prolonged exposure; PSS-SR, Posttraumatic Stress Symptom Scale Self-Report; PTCI, Posttraumatic Cognitions Inventory; and WL, waiting list. a e CAPS, PSS-SR, and PTCI scores re ect the estimated marginal mean (95% CI) from the LMM analyses. Between-group e ect sizes are Cohen d based on estimated data from the LMM procedure. e reported e ect sizes concern the di erences between the 2 treatment conditions and the WL condition (PE vs WL and EMDR vs WL) at the di erent time points. Results from the LMM analyses concern the di erences at the di erent time points for PE vs WL and for EMDR vs WL. 
DISCUSSION
Both PE therapy and EMDR therapy were more effective than the WL condition in reducing trauma symptoms and achieving loss of PTSD diagnosis among participants with severe PTSD and psychotic disorders. Prolonged exposure therapy was more effective than WL in achieving full remission, remission, while EMDR therapy was not.
We found no differences in head-to-head comparisons of the 2 active treatments in any of the outcomes.
Similar to most trauma treatment trials, treatment effects were observed directly after treatment and persisted over time. 41 Moreover, in the present sample with comorbid psychotic disorder, change rates in the diagnostic status were comparable to those reported in a meta-analysis 6 of general samples. The dropout rate was low and comparable to that of other trials. 42 Most important, both treatments were found to be safe and did not result in severe adverse events.
Some of the patients in the control condition achieved remission. This might be the result of anticipation of a positive outcome of treatment and setting a date for the first session.
Also, exposure to an extensive trauma interview and repeated assessments in the study protocol 21 may have functioned as covert exposure. 43 Last, trauma symptoms appear to fluctuate over time, 44 and long-term remission rates without specific treatment are high in PTSD. 45 Therefore, future studies should include an active non-trauma-focused (eg, befriending) control group to control for factors such as therapy time and attention.
The present results can be generalized to routine clinical practice. We used standard protocols of guideline trauma treatments in a sample of patients with psychotic disorders and severe psychopathology (including current paranoia, auditory verbal hallucinations, depression, and high suicide risk). Psychotherapeutic stabilization was not applied and appears unnecessary; it may even needlessly delay treatment. 13 The dropout rate was comparable to that in the trial by Mueser and colleagues 16 and was lower than that in an open study 17 using stabilizing interventions.
Dissemination of effective trauma treatments to clinical practice appears to be problematic, 9, [46] [47] [48] and posttraumatic stress disorder is missed in most patients with a psychotic disorder. 49, 50 These factors decrease the chance that patients with psychosis and PTSD will receive evidence-based trauma treatment. There are multiple reasons for this, but the most important factors seem to be fear of symptom exacerbation, safety
TRAUMA-FOCUSED TREATMENT IN PSYCHOSIS
· 55 · issues, and questions about tolerability. 13, 46 The fact that professionals are particularly reluctant to treat trauma in psychosis 9, 10 is not based on empirical evidence. 47, 51 Exclusion of patients with psychotic disorders from effective trauma treatments has been the norm in both clinical practice and research. 14 Even researchers stressing the importance of broadening the inclusion criteria for trauma treatment studies indicate that schizophrenia is a reasonable exclusion criterion. 6 The present results are at odds with these prejudices.
The strengths of this study are the sample size, the generalizability to clinical practice owing to the use of standard protocols with patients in routine long-term care, the correction for unblinding, and the limited loss to follow-up. We believe that this study demonstrates the efficacy and safety of trauma treatment in psychosis.
There are several limitations. The first limitation is that treatment consisted of only 8
sessions. Most participants had experienced multiple childhood traumas, and for some participants 8 sessions were probably too few to significantly affect trauma symptoms.
The second limitation is the fact that this study was powered to find medium to large effects. Therefore, small effects between conditions may not have been detected. The third limitation is that experts supervised the therapies, whereas similar supervision may not always be available in clinical practice. The fourth limitation is that treatment as usual for psychosis may vary between countries. Most participants in the present trial were treated in assertive outreach teams.
CONCLUSIONS
This study demonstrates that standard PE and EMDR protocols are effective, safe, and feasible in patients with psychosis and comorbid PTSD without using stabilizing psychotherapeutic interventions. One in 8 patients with a psychotic disorder has PTSD. 
